Rehacom or Wechsler Assessment Methodology in Cognitive Abilities of Normal Children: Correlation Study
11. september 2026 opdateret af: Mostafa S Ali, Cairo University
The purpose of this study is to investigate the relationship between a computerized cognitive assessment tool (Rehacom) and a traditional intelligence scale (Wechsler Intelligence Scale for Children) in assessing cognitive abilities among typically developing children.
Specifically, the study aims to determine whether Rehacom subtests (logical reasoning, memory for words, and visual field) correlate significantly with total Wechsler scores.
Studieoversigt
Status
Afsluttet
Betingelser
Detaljeret beskrivelse
Cognitive assessment in children requires reliable and valid measurement tools. Traditional paper-and-pencil intelligence tests, such as the Wechsler scales, are considered the gold standard; however, they require lengthy administration and significant examiner expertise. Computerized systems like Rehacom offer potential advantages including standardized administration, precise timing, and automated scoring. Nevertheless, the convergent validity between Rehacom and traditional measures in healthy children has not been thoroughly established. Prior research suggests that computerized cognitive tasks may share moderate variance with traditional IQ tests, particularly in domains such as logical reasoning and memory, but specific visual field tasks may assess distinct constructs. Therefore, empirical validation is needed to guide clinicians in interpreting Rehacom scores.
HYPOTHESES:
- There will be no significant correlation between Rehacom logical reasoning scores and total Wechsler scores.
- There will be no significant correlation between Rehacom memory for words scores and total Wechsler scores.
- There will be no significant correlation between Rehacom visual field measures and total Wechsler scores.
Undersøgelsestype
Observationel
Tilmelding (Faktiske)
150
Kontakter og lokationer
Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.
Studiesteder
-
-
Giza Governorate
-
Giza, Giza Governorate, Egypten, 11432
- Cairo University
-
-
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
- Barn
Tager imod sunde frivillige
Ja
Prøveudtagningsmetode
Sandsynlighedsprøve
Studiebefolkning
This study employs a cross-sectional correlational design.
Following ethical approval and obtaining informed consent from parents or legal guardians, 150 typically developing children (age range 9-11 years) will be recruited from mainstream primary schools.
Beskrivelse
Inclusion Criteria:
- Age between 9 and 11 years.
- Normal intellectual development and academic progress according to teacher reports.
- No documented history of neurological, psychiatric, or learning disorders.
Exclusion Criteria:
- Previous diagnosis of attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), or intellectual disability.
- History of significant head injury or chronic medical conditions affecting cognitive functioning.
- Receiving special educational support services.
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
logical reasoning
Tidsramme: 2 weeks
|
it is measured by Rehacom Cognitive Assessment System and Wechsler Intelligence Scale for Children (appropriate edition) Average (90-110): Represents typical intellectual functioning for a person's age group.Low/High Average (80-89 / 110-119): Falls just below or above the typical average range.Gifted (130 and above): Indicates superior or highly advanced cognitive abilities.Extremely Low (69 and below): Suggests significant cognitive delays or intellectual disability.
|
2 weeks
|
|
memory for words
Tidsramme: 2 weeks
|
it is measured by Rehacom Cognitive Assessment System and Wechsler Intelligence Scale for Children (appropriate edition) Average (90-110): Represents typical intellectual functioning for a person's age group.Low/High Average (80-89 / 110-119): Falls just below or above the typical average range.Gifted (130 and above): Indicates superior or highly advanced cognitive abilities.Extremely Low (69 and below): Suggests significant cognitive delays or intellectual disability.
|
2 weeks
|
|
visual field left
Tidsramme: 2 weeks
|
it is measured by Rehacom Cognitive Assessment System and Wechsler Intelligence Scale for Children (appropriate edition) Average (90-110): Represents typical intellectual functioning for a person's age group.Low/High Average (80-89 / 110-119): Falls just below or above the typical average range.Gifted (130 and above): Indicates superior or highly advanced cognitive abilities.Extremely Low (69 and below): Suggests significant cognitive delays or intellectual disability.
|
2 weeks
|
|
visual field right
Tidsramme: 2 weeks
|
it is measured by Rehacom Cognitive Assessment System and Wechsler Intelligence Scale for Children (appropriate edition) Average (90-110): Represents typical intellectual functioning for a person's age group.Low/High Average (80-89 / 110-119): Falls just below or above the typical average range.Gifted (130 and above): Indicates superior or highly advanced cognitive abilities.Extremely Low (69 and below): Suggests significant cognitive delays or intellectual disability.
|
2 weeks
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Sponsor
Efterforskere
- Ledende efterforsker: Mostafa S. Ali, Phd, Cairo University
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
20. marts 2026
Primær færdiggørelse (Faktiske)
20. juni 2026
Studieafslutning (Faktiske)
10. juli 2026
Datoer for studieregistrering
Først indsendt
7. september 2026
Først indsendt, der opfyldte QC-kriterier
10. september 2026
Først opslået (Faktiske)
14. september 2026
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
15. september 2026
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
11. september 2026
Sidst verificeret
1. september 2026
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Andre undersøgelses-id-numre
- P.T.REC/012/006626
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .